Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis.
To examine whether ultralong GnRH analog (GnRH-a) therapy after surgical treatment of endometriosis and before ART influences the pregnancy rate. Prospective, randomized, controlled study. University clinic for reproductive medicine and gynecologic endocrinology. One hundred ten patients with stage II to IV endometriosis according to ASRM criteria. Fifty-five patients received GnRH-a for 6 months after surgery and subsequently underwent up to 3 cycles of ART, and 55 patients received 3 cycles of ART alone immediately after surgery. Clinical pregnancy rates. The pregnancy rate per patient was higher among patients who received follow-up treatment with GnRH-a. The same results were found in patients with stage III or IV endometriosis who were undergoing IUI or IVF/ICSI. Ultralong GnRH-a therapy increases the pregnancy rate of ART in patients with severe endometriosis.